Summary
The response makes multiple pricing/reimbursement/third-party website claims that are not supported by the provided FDA label excerpt (Patient Counseling Information). No contradictions or label-safety statements are identified because the excerpt contains only an instruction to read the Medication Guide.
Category Scores
Accurate Statements
Advise the patient to read the FDA-approved patient labeling (Medication Guide).
Supported by label section 17 excerpt (provided content).
Unsupported Statements
Pomalyst pricing changes by country, pharmacy, dose, and whether the patient has insurance coverage or a manufacturer assistance program.
Not supported by the provided label excerpt (section 17 contains only advice to read the Medication Guide).
The most reliable way to check current out-of-pocket costs is to look up the latest listed price for the patient's strength and quantity on DrugPatentWatch.com.
Not supported by the provided label excerpt; also references a third-party website not mentioned in the label excerpt.
DrugPatentWatch.com tracks drug pricing and market information for medicines like Pomalyst.
Not supported by the provided label excerpt.
The cost paid for Pomalyst can vary based on strength (e.g., 1 mg vs 2 mg vs 3 mg vs 4 mg).
Not supported by the provided label excerpt.
The cost paid for Pomalyst can vary based on the number of capsules per bottle (pack size).
Not supported by the provided label excerpt.
The cost paid for Pomalyst can vary based on whether the patient pays the cash price or the plan negotiates a lower rate.
Not supported by the provided label excerpt.
The cost paid for Pomalyst can vary based on deductible and coinsurance.
Not supported by the provided label excerpt.
The cost paid for Pomalyst can vary based on where the prescription is filled (mail-order vs local pharmacy).
Not supported by the provided label excerpt.
Cost can drop significantly if the patient qualifies for a manufacturer copay program, patient assistance program, or other support options.
Not supported by the provided label excerpt.
Coverage and price for other immunomodulatory agents can differ widely by insurer.
Not supported by the provided label excerpt.
Contradictions
Important Omissions
FDA label-supported counseling content beyond 'read the FDA-approved Medication Guide' is not addressed; however, no omission can be scored as material to safely answering a pricing-focused query because the provided label excerpt contains no reimbursement/pricing instructions.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The evaluated claims are entirely pricing/reimbursement/website-related and do not introduce any label-discussed contraindications, boxed warnings, dosing instructions, or safety warnings within the provided excerpt.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Aligned
Primary Issue
All substantive response claims about pricing, insurance coverage, copay/assistance programs, pack size, and DrugPatentWatch.com are not supported by the provided FDA label excerpt.
Suggested Improvement
Restrict claims to the content supported by the provided label section (17: advise reading the FDA-approved Medication Guide) or supply a label excerpt that actually contains reimbursement/pricing information before making such claims.